Crypto Market in Focus as Banks Raise US PCE Forecasts Ahead of Fed Rate Hike Decision
Investment Opportunities
Startups
Ra capital management director buys $412,776 in Artiva Biotherapeutics
RA Capital Management, L.P., a reporting person identified as both a director and a 10% owner of Artiva Biotherapeutics, Inc. (), acquired 41,319 shares of the company’s common stock on July 24, 2026. The total value of these
